Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 1, 2011, Pages 70-73

  Oliveira, Fabiano ^d   Bafica, Andre ^e   Rosato, Andrea B ^a   Favali, Cecilia B F ^f   Costa, Jackson M ^a   Cafe, Virginia ^b   Barral Netto, Manoel ^a,c   Barral, Aldina ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia iii INCT   (Brazil)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^f INSTITUTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; TUMOR NECROSIS FACTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL EVALUATION; FEMALE; FOLLOW UP; HEALING; HUMAN; HYPOTHESIS; IMMUNOSTIMULATION; LEISHMANIA BRAZILIENSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; SKIN LEISHMANIASIS; SKIN TEST; TREATMENT DURATION; ULCER;

ADOLESCENT; ADULT; AGED; ANTIGENS, PROTOZOAN; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; LEISHMANIA BRAZILIENSIS;

EID: 79960206524     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0680     Document Type: Article

References (19)

1. Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, Barral A, 2005. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop 94: 55-59. (Pubitemid 40445380)
2. Rosa AC, Cuba CC, Vexenat A, Barreto AC, Marsden PD, 1988. Predominance of Leishmania braziliensis braziliensis in the regions of Tres Bracos and Corte de Pedra, Bahia, Brazil. Trans R Soc Trop Med Hyg 82: 409-410.
3. Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM, 1995. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg 53: 256-259.
4. Gaafar A, Veress B, Permin H, Kharazmi A, Theander TG, el Hassan AM, 1999. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol 91: 314-320. (Pubitemid 29250218)
5. Pompeu MM, Brodskyn C, Teixeira MJ, Clarencio J, Van Weyenberg J, Coelho IC, Cardoso SA, Barral A, Barral-Netto M, 2001. Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect Immun 69: 7453-7460. (Pubitemid 33086570)
6. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Gollob KJ, 2004. Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation . Clin Exp Immunol 136: 341-348. (Pubitemid 38543455)
7. D'Oliveira A Jr, Machado P, Bacellar O, Cheng LH, Almeida RP, Carvalho EM, 2002. Evaluation of IFN-gamma and TNF-alpha as immunological markers of clinical outcome in cutaneous leishmaniasis. Rev Soc Bras Med Trop 35: 7-10.
8. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM, 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70: 6734-6740. (Pubitemid 35387904)
9. Bafica A, Oliveira F, Freitas LA, Nascimento EG, Barral A, 2003. American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. Int J Dermatol 42: 203-207. (Pubitemid 41709833)
10. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ, 2005. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 101: 226-230. (Pubitemid 41368083)
11. Reed SG, Badaro R, Masur H, Carvalho EM, Lorenco R, Lisboa A, Teixeira R, Johnson WD Jr, Jones TC, 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 35: 79-85. (Pubitemid 16140841)
12. Machado P, Araujo C, Da Silva AT, Almeida RP, D'Oliveira A Jr, Bittencourt A, Carvalho EM, 2002. Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis 34: E69-E73.
13. Llanos-Cuentas EA, Marsden PD, Lago L, Barreto AC, Cuba CC, Johnson WD, 1984. Human cutaneous leishmaniasis in Três Braços, Bahia-Brazil. An area of Leishmania braziliensis transmission. II. Cutaneous disease presentation and evolution. Rev Soc Bras Med Trop 17: 169-177.
14. Van de Kerkhof PC, Van Bergen B, Spruijt K, Kuiper JP, 1994. Age-related changes in wound healing. Clin Exp Dermatol 19: 369-374. (Pubitemid 24308593)
15. Castes M, Trujillo D, Rojas ME, Fernandez CT, Araya L, Cabrera M, Blackwell J, Convit J, 1993. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res 26: 233-238. (Pubitemid 24109052)
16. Da-Cruz AM, de Oliveira MP, De Luca PM, Mendonca SC, Coutinho SG, 1996. Tumor necrosis factor-alpha in human american tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 91: 225-229. (Pubitemid 126464626)
17. Barral-Netto M, Badaro R, Barral A, Almeida RP, Santos SB, Badaro F, Pedral-Sampaio D, Carvalho EM, Falcoff E, Falcoff R, 1991. Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 163: 853-857.
18. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC, 2000. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 8: 13-25. (Pubitemid 30140796)
19. Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, Carvalho EM, 2001. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 65: 87-89. (Pubitemid 32746963)